What is Geno Technology?
Geno Technology, also known as G-Biosciences, is a St. Louis, Missouri-based biotechnology manufacturer dedicated to producing high-quality products for the research industry. The company offers a comprehensive portfolio of protein research products, bioassays, and molecular biology tools. Geno Technology is recognized for its commitment to quality, competitive pricing, efficient delivery, and superior customer service, providing essential solutions for protein assays, genomic DNA purification, and cell toxicity studies.
How much funding has Geno Technology raised?
Geno Technology has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Geno Technology
PPP
Public-Private Partnership
What's next for Geno Technology?
The substantial late-stage funding, characterized as a major strategic investment, positions Geno Technology for accelerated scaling and market expansion. This capital infusion is expected to fuel further product development, enhance manufacturing capabilities, and potentially broaden its reach within the global research community. The company's focus on quality and customer satisfaction, combined with this significant financial backing, suggests a strategic push to solidify its leadership in specialized biotechnology research products.
See full Geno Technology company page
